TrialBreast cancer research and treatment2011

SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.

Robert B Livingston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.